Institut de Physique et de Chimie des Matériaux de Strasbourg IPCMS, UMR CNRS-UdS 7504, 23 rue du Loess, BP 43, 67034 STRASBOURG CEDEX 2, France.
Nanomedicine (Lond). 2015;10(6):977-92. doi: 10.2217/nnm.14.196.
Nanomedicine can take advantage of the recent developments in nanobiotechnology research areas for the creation of platforms with superior drug carrier capabilities, selective responsiveness to the environment, unique contrast enhancement profiles and improved accumulation at the disease site. Colloidal inorganic nanoparticles (NPs) have been attracting considerable interest in biomedicine, from drug and gene delivery to imaging, sensing and diagnostics. It is essential to modify the NPs surface to have enhanced biocompatibility and reach multifunctional systems for the in vitro and in vivo applications, especially in delivering drugs locally and recognizing overexpressed biomolecules. This paper describes the rational design for dendrimer-nanoparticle conjugates elaboration and reviews their state-of-the-art uses as efficient nanomedicine tools.
纳米医学可以利用纳米生物技术研究领域的最新进展,来创建具有卓越药物载体能力、对环境具有选择性响应、独特的对比增强特性以及在疾病部位更好聚集的平台。胶体无机纳米粒子(NPs)在生物医药领域引起了相当大的兴趣,从药物和基因传递到成像、传感和诊断。对 NPs 表面进行修饰以提高其生物相容性并达到多功能系统对于体外和体内应用至关重要,特别是在局部递药和识别过表达的生物分子方面。本文描述了树枝状聚合物-纳米粒子缀合物的合理设计,并综述了其作为高效纳米医学工具的最新应用。
Nanomedicine (Lond). 2015
Nanomedicine. 2010-4-22
Artif Cells Nanomed Biotechnol. 2016
Arch Pharm Res. 2013-11-12
Expert Rev Mol Diagn. 2012-1
Nat Rev Bioeng. 2025-3
Pharmaceutics. 2021-7-27
J Control Release. 2016-10-28